Strengthening the Patient-Provider Therapeutic Alliance In Obesity Care: Minimizing Stigma and Increasing Patient Engagement—Obesity Series Podcast 3

Important: After listening to the podcast, you will need to visit myCME to complete the post-assessment and evaluation and to claim your credits and certificate for this activity. Please go to www.mycme.com/obesity3 on any browser to complete the activity.

Description

Poorer health outcomes among individuals with overweight and obesity are made more likely and are being exacerbated by their experiencing weight-related stigma in healthcare settings, resulting in shorter office visits, less likelihood of preventive health screening, and fewer appropriate medical treatments.

In this audio activity, Dr. Robert Kushner and Dr. Pamela Kushner review some of the potential biases that healthcare providers may unknowingly harbor related to obesity, and how these perceptions can negatively impact patient care. The faculty provide practical strategies that clinicians can implement to improve communication with their patients with obesity, and discuss methods for keeping patients engaged in obesity care over the long-term.

This activity is designed for primary care providers (MDs/DOs, PAs, NPs), endocrinologists, cardiologists, dieticians/nutritionist, pharmacists, and other members of the multidisciplinary obesity care team.

This activity is supported by an educational grant from Novo Nordisk.

At the conclusion of this activity, participants should be better able to:

• Implement practical interventions to destigmatize obesity, surmount barriers to maintenance of weight loss over the long term, and enhance patient engagement

Faculty

Pamela Kushner, MD, FAAFP
Clinical Professor
University of California at Irvine
Irvine, CA

Dr. Pamela Kushner is a consultant for Abbott, Intuity Medical, Inc., and Phathom Pharmaceuticals and is speaker and consultant for AstraZeneca, Eli Lilly and Company, GSK, and Janssen Pharmaceuticals, Inc.

Robert F. Kushner, MD, MS, FACP, DABOM
Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Director, Center for Lifestyle Medicine, Northwestern Medicine
Chicago, IL

Dr. Robert Kushner is on the advisory board of Novo Nordisk and WW International, Inc., is a consultant for Pfizer Inc. and Altimmune, and has received research funding from Epitomee Medical.

All of the relevant financial relationships listed for these individuals have been mitigated.